All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
More information on our cookie policy.
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Special reports
Artificial intelligence
Coronavirus
Diagnosing and tracking COVID-19
Drugs to Watch 2020
The next pandemic
Premium reports
BioWorld Financings Reports
Disease Forecast Reports
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 16, 2021
Home
» Agenus reports additional confirmed objective clinical responses from phase I/II trial of AGEN-1181
Agenus reports additional confirmed objective clinical responses from phase I/II trial of AGEN-1181
Feb. 10, 2021
No Comments
Article reprints
Source:
https://science.bioworld.com/ddn/article.do?id=176397
BioWorld Science
Related Articles
Translate Bio reports second interim analysis of phase I/II trial of MRT-5005 for cystic fibrosis
